Page 47 - CIBERSAM2016-ENG

Most relevant scientific articles
• Zalsman G, Hawton K, Wasserman D, van Heeringen K, Arensman E, Sarchiapone M et al. Suicide prevention strategies revisited: 10-year systematic review.The lancet. Psychiatry. 2016;3(7):646-59.
• Garcia-Portilla M.P., Garcia-Alvarez L., Sarramea F., Galvan G., Diaz-Mesa E., Bobes-Bascaran T. et al. It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline. Schizophrenia Research. 2016.
• Cabrera B., Bioque M., Penades R., Gonzalez-Pinto A., Parellada M., Bobes J. et al. Cognition and psychopathology in first-episode psychosis: are they related to inflammation? Psychological Medicine. 2016;1-12.
• Bonnin C.M., Torrent C., Arango C., Amann B.L., Sole B., Gonzalez-Pinto A. et al. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional Outcome. British Journal of Psychiatry. 2016;208(1):87-93.
• McMahon E.M., Corcoran P., O’Regan G., Keeley H., Cannon M., Carli V. et al. Physical activity in European adolescents and associations with anxiety, depression and well-being. European Child and Adolescent Psychiatry. 2016;1-12.
Hightlights
The G05, in 2016, was involved in several research projects funded by the Institute of Health Carlos III, with members of the group being the PI in three of them: “Differential biomarkers of the negative dimension
of schizophrenia”, “Neuropsychological functioning and inflammatory profile in suicidal behavior” and “Validation of a clinical staging model for bipolar disorder.
We also participated in three clinical trials: “Interventional, randomized, double-blind, active-controlled, fixed-dose study of Lu AF35700 in patients with Treatment-resistant Schizophrenia”, “A 52-week, prospective, open-label, multicentre, international study on the transition to a quarterly formulation of paliperidone palmitate in patients with schizophrenia previously stabilized with a monthly formulation of paliperidone palmitate” and “European Long-acting Antipsychotics in Schizophrenia Trial” (EULAST ).
A specific multi-component program for smoking cessation in patients with schizophrenia or bipolar disorder has been developed and their efficacy and security has been demonstrated.
Members of the G05 have participated in the elaboration of the Clinical Guideline for the treatment of dual pathology in the adult population.
During 2016 two doctoral thesis have been directed and defensed, whose titles are: “Adaptation and validation in Spanish of the sixth version of the Addiction Severity Index (ASI-6)” and “Differential biomarkers of schizophrenia”
The thesis entitled “Monitoring of suicidal behavior in the Sanitary Area IV of Asturias” by Dr. Patricia Burón Fernández, has been awarded to the prize of best Doctoral Thesis of the University of Oviedo (Knowledge Area of Psychology).
Two members of the group are Editors in chief of two indexed scientific Journals with impact factor: Revista de Psiquiatría y Salud Mental and Adicciones.
Members of the G05 actively participated in Boards of European and National Scientific Societies and in Scientific and/or Organizer Committees of National and International Conferences/Congress.
SAM
research groups 47